Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/16/2012CA2827017A1 B-type plexin antagonists and uses thereof
08/16/2012CA2827007A1 Ch2 domain template molecules derived from rational grafting of donor loops onto ch2 scaffolds
08/16/2012CA2826942A1 Hla-restricted, peptide-specific antigen binding proteins
08/16/2012CA2826582A1 Adjuvant compositions with 4-1bbl
08/16/2012CA2826566A1 Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use
08/16/2012CA2826564A1 Treatment of osteoarthritis and pain
08/16/2012CA2826563A1 Methods and systems for treating or preventing pregnancy-related hypertensive disorders
08/16/2012CA2825791A1 Apoe immunotherapy
08/16/2012CA2825770A1 Immunogenic composition comprising alpha-hemolysin oligopeptides
08/16/2012CA2825495A1 Antigenic gly1 polypeptides
08/16/2012CA2825493A1 Antigenic gly1 polypeptide
08/16/2012CA2824253A1 Mutant interleukin-2 polypeptides
08/15/2012EP2487189A1 Monoclonal antibodies for treatment of cancer
08/15/2012EP2487188A2 IL-17 receptor A antigen binding proteins
08/15/2012EP2487187A2 Human cytomegalovirus neutralising antibodies and use thereof
08/15/2012EP2487186A1 Immunoregulatory structures from normally occuring proteins
08/15/2012EP2486941A1 Human antibodies that bind CXCR4 and uses thereof
08/15/2012EP2486940A2 Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof
08/15/2012EP2486939A1 Adenoviral vector encoding malaria antigen
08/15/2012EP2486938A1 Vaccine composition containing synthetic adjuvant
08/15/2012EP2486933A1 Monomethylvaline compounds conjugated with antibodies
08/15/2012EP2486791A2 Highly pathogenic avian influenza virus protein vaccine derived from transgenic plants, and method for preparing same
08/15/2012EP2486138A1 Generation of a broad t-cell response in humans against hiv
08/15/2012EP2486133A1 Vaccines comprising heat-sensitive transgenes
08/15/2012EP2486060A1 Siglec 15 antibodies in treating bone loss-related disease
08/15/2012EP2486055A2 Human domain antibodies against components of the human insulin-like growth factor (igf) system
08/15/2012EP2486054A2 Recombinant antibodies against h1n1 influenza
08/15/2012EP2486046A1 A cytolytic rtx-toxin from gallibacterium anatis
08/15/2012EP2485764A2 Selectively disrupted whole-cell vaccine
08/15/2012EP2485763A2 Il-17 family cytokine compositions and uses
08/15/2012EP2485762A1 Anti-vla-4 related assays
08/15/2012EP2485761A1 Methods and compositions for increasing iduronate 2-sulfatase activity in the cns
08/15/2012EP2485760A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
08/15/2012EP2485759A2 Methods, agents and peptides for inducing an innate immune response in hiv vaccination
08/15/2012EP2485758A1 Immunopotentiator-linked oligomeric influenza immunogenic compositions
08/15/2012EP2485757A1 Staphylococcus aureus divi1b for use as vaccine
08/15/2012EP2485752A2 Enterotoxigenic e. coli fusion protein vaccines
08/15/2012EP2485744A2 Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease
08/15/2012EP2485739A1 Methods and compositions for maintenance of a functional wound
08/15/2012EP2485725A2 Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
08/15/2012EP2171448B1 Methods for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells
08/15/2012EP2153843B1 Compositions and methods for the diagnosis and treatment of tumor
08/15/2012EP2115134B1 citrullinated enolase peptides
08/15/2012EP2076542B1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers
08/15/2012EP1993596B1 Cancer vaccine
08/15/2012EP1986632B1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
08/15/2012EP1963558B1 Method for preparing a textile material
08/15/2012EP1945659B1 Influenza viruses able to infect canids, uses thereof
08/15/2012EP1874345B1 Immunostimulatory compositions
08/15/2012EP1802344B1 Antibody formulation in histidine-acetate buffer
08/15/2012EP1594524B1 Use of tryptanthrin compounds for immune potentiation
08/15/2012EP1534312B1 Staphylococcal superantigens for combination treatment of lung tumors
08/15/2012EP1515749B1 Combined use of a modulator of cd3 and a glp-1 compound
08/15/2012EP1420716B1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
08/15/2012EP1294391B1 Combination of agents for inhibiting transplant rejection
08/15/2012CN1748791B Haemorrhagic E, coli 0157:H7 vaccine for human and livestock prevention and preparing method
08/15/2012CN102639150A AX213 and AX132 PCSK9 antagonists and variants
08/15/2012CN102639149A Secreted aP2 and methods of inhibiting same
08/15/2012CN102639148A Inactivated poultry vaccine ?
08/15/2012CN102639147A RSV F protein compositions and methods for making same
08/15/2012CN102639146A Proteasome inhibitors and uses thereof
08/15/2012CN102639142A Inhibition of endosomal toll-like receptor activation
08/15/2012CN102634540A Plastid genetic engineering via somatic embryogenesis
08/15/2012CN102634489A Recombinant turkey herpesvirus and application thereof
08/15/2012CN102633898A Optimization method of Hib polysaccharide and protein binding process
08/15/2012CN102633893A Hypo- and hyper-acetylated meningococcal capsular saccharides
08/15/2012CN102633881A Antibodies directed to her-3 and uses thereof
08/15/2012CN102633880A Optimized fc variants and methods for their generation
08/15/2012CN102631675A High-efficiency CpG preparation, preparation method thereof and application
08/15/2012CN102631674A Novel muscovy duck reovirus disease vaccine and application thereof
08/15/2012CN102631673A Method for foot-and-mouth disease vaccine concentration and purification
08/15/2012CN102631672A Lyophilized inactivated Japanese encephalitis vaccine
08/15/2012CN102631671A Therapeutic vaccine for improving vaccine induced cytotoxicity T cellular reaction
08/15/2012CN102631670A Vaccine compositions comprising a saponin adjuvant
08/15/2012CN102631367A Composition with good curative effect by aiming at various osteoarthritis symptoms
08/15/2012CN102199612B Nucleotide sequence used in preparation of Mycobacterium smegmatis vaccine and application thereof
08/15/2012CN102178655B Preparation method of osteocalcin (OC) freeze-dried powder preparation for injection
08/15/2012CN101948809B Inactivated vaccine for preventing duck viral hepatitis and preparation method thereof
08/15/2012CN101864434B Sheep aphthovirus Asial type multi-epitope recombinant vaccine and preparation method thereof
08/15/2012CN101815532B Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient
08/15/2012CN101732333B Medicament for treating cancer
08/15/2012CN101619092B Tumor antigen TRAG-3 mimotope peptide and application thereof
08/15/2012CN101237882B Humanized anti-CD40 antibodies and their methods of use
08/15/2012CN101139589B Preparation method of immortalized cell for expression of infectious bursal virus VP2 gene encoding protein
08/15/2012CN101094594B Modulation of immunostimulatory properties by small oligonucleotide-based compounds
08/15/2012CN101037475B Chimerical receptor and preparation method and usage
08/14/2012USRE43581 Peptide epitopes of apolipoprotein B
08/14/2012US8242247 Bivalent, bispecific antibodies
08/14/2012US8242239 MHC molecule-binding tumor-associated peptides
08/14/2012US8242238 Surface protein (HBsAg) variant of the hepatitis B virus
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8242089 Sphingolipids polyalkylamine conjugates for use in transfection
08/14/2012US8242084 Dimerized peptide
08/14/2012US8242074 Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
08/14/2012US8241899 Anti-TNF antibodies, compositions, methods and uses
08/14/2012US8241886 Formulations for preservation of rotavirus
08/14/2012US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
08/14/2012US8241844 Methods and compositions for modulating an immune response with immunogenic oligonucleotides
08/14/2012US8241843 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
08/14/2012US8241656 Articles including natural biodegradable polysaccharides and uses thereof
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 1823